Assura PLC Updated results presentation timing (1781L)
May 12 2022 - 2:02AM
UK Regulatory
TIDMAGR
RNS Number : 1781L
Assura PLC
12 May 2022
12 May 2022
Assura plc
Updated results presentation timing
Please note that the timing of the results presentation on
Wednesday 18 May 2022 has changed from our previous
announcement.
Assura plc ("the Company"), the UK's leading primary care
property investor and developer will announce Annual Results for
the year ended 31 March 2022 on Wednesday 18 May 2022.
A presentation for analysts and investors, immediately followed
by a live Q&A with members of the senior management team can be
viewed at 11.00 am BST at the following link:
https://webcasting.brrmedia.co.uk/broadcast/625e82ca841dd838fd0be3a3
Presentation via the Investor Meet Company platform
Separately, Jonathan Murphy (CEO) and Jayne Cottam (CFO) will
host a live presentation relating to the Annual Results for the
year ended 31 March 2022 via the Investor Meet Company platform on
Thursday 9 June 2022 at 11.30 am BST.
The presentation is open to all existing and potential
investors. Questions can be submitted pre-event via the Investor
Meet Company dashboard until 9.00 am the day before the meeting or
at any time during the live presentation.
Investors can sign up to Investor Meet Company for free and
register to follow Assura plc via this link:
https://www.investormeetcompany.com/assura-plc/register-investor
Investors who already follow Assura plc on the Investor Meet
Company platform will automatically be invited to the event.
- Ends -
For more information, please contact:
Assura plc Tel: 01925 945354
David Purcell, Investor Relations E mail: Investor@assura.co.uk
Director
Finsbury Glover Hering Tel: 0207 251 3801
Gordon Simpson Email: Assura@Finsbury.com
James Thompson
Notes to Editors
Assura plc is a national healthcare premises specialist and UK
REIT based in Warrington, UK - caring for more than 600 primary
healthcare buildings, from which almost seven million patients are
served.
A constituent of the FTSE 250 and the EPRA* indices, as at 30
September 2021, Assura's portfolio was valued at GBP2,595
million.
At Assura, we BUILD for health. Assura builds better spaces for
people and places, invests in skills and inspires new ways of
working, and unlocks the power of design and innovation to deliver
lasting impact for communities - aiming for six million people to
have benefitted from improvements to and through its healthcare
buildings by 2026.
Assura is leading for a sustainable future, targeting net zero
carbon across its portfolio by 2040.
Further information is available at www.assuraplc.com
*EPRA is a registered trademark of the European Public Real
Estate Association.
Assura plc LEI code: 21380026T19N2Y52XF72
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NORQFLFFLELEBBE
(END) Dow Jones Newswires
May 12, 2022 02:02 ET (06:02 GMT)
Assura (LSE:AGR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Assura (LSE:AGR)
Historical Stock Chart
From Jul 2023 to Jul 2024